Current Cardiology Reports

• 

  Publication Venue For

  • Intensive Care Unit Management of the Adult with Congenital Heart Disease..  22:136. 2020
  • Pericardial Cysts: a Contemporary Comprehensive Review.  21. 2019
  • The Autonomic Nervous System and Hypertension: Ethnic Differences and Psychosocial Factors..  21:15. 2019
  • Adverse Remodeling and Reverse Remodeling After Myocardial Infarction..  19:71. 2017
  • Challenges with Evidence-Based Management of Stable Ischemic Heart Disease.  19. 2017
  • Relationship Between Sedentary Behavior and Cardiovascular Risk.  18. 2016
  • Role for Combination Therapy in Diabetic Dyslipidemia.  17. 2015
  • Overview of the US FDA medical device approval process..  16:494. 2014
  • Subclinical Cardiovascular Disease Assessment in Persons with Diabetes.  15. 2013
  • Interventional Treatment of Hypertension: A New Paradigm.  15:1-8. 2013
  • Which Antithrombin for Whom? Identifying the Patient Population that Benefits Most from Novel Antithrombin Agents.  14:493-501. 2012
  • Promises of PAR-1 inhibition in acute coronary syndrome..  14:32-39. 2012
  • Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia..  9:396-405. 2007
  • Advances in antithrombotic therapy in acute myocardial infarction: the ExTRACT-TIMI 25 and OASIS-6 Trials..  8:279-281. 2006
  • How aggressive should lipid lowering be among patients with acute coronary syndromes?.  7:283-287. 2005
  • Issues with care in the elderly patient presenting with acute ischemia..  7:270-275. 2005
  • Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes..  7:263-269. 2005
  • Use of cardiac magnetic resonance to assess viability..  7:59-64. 2005
  • Update on implantable cardioverter defibrillator trials..  6:327-332. 2004
  • The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromes..  6:300-307. 2004
  • Acute coronary syndromes in patients with diabetes mellitus: diagnosis, prognosis, and current management strategies..  5:296-302. 2003
  • ST-segment monitoring in patients with acute coronary syndromes..  5:278-283. 2003
  • New biomarkers in the risk stratification of patients with suspected acute myocardial infarction..  4:341-347. 2002
  • Choice of agents to limit the coagulation cascade in acute coronary syndromes.  4:272-277. 2002
  • Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia..  3:362-370. 2001
  • Genomics and the pathophysiology of heart failure..  3:198-207. 2001
  • Rational use of inotropic therapy in heart failure..  3:108-113. 2001
  • Myocardial gene transfer..  3:37-42. 2001
  • Oral platelet glycoprotein IIb/IIIa inhibition..  2:372-377. 2000
  • Treatment strategies for microvascular dysfunction following acute myocardial infarction..  2:405-410. 2000
  • Novel inhibitors of factor X for use in cardiovascular diseases.  2:395-404. 2000
  • Combination drug therapy for combined hyperlipidemia..  1:244-250. 1999